ReviewBreast cancer research : BCR2026

Targeting drug resistance in breast cancer: a dual-perspective landscape analysis of PROTACs from bench to bedside.

Yinlong Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.